These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23027448)

  • 1. Sex and gender in adverse drug events, addiction, and placebo.
    Franconi F; Campesi I; Occhioni S; Antonini P; Murphy MF
    Handb Exp Pharmacol; 2012; (214):107-26. PubMed ID: 23027448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Men and women respond differently to drugs. Hormone-dependent pharmacodynamic differences are rarely studied].
    Vinge E
    Lakartidningen; 1998 Jul; 95(28-29):3177-82. PubMed ID: 9700262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of a mixed-gender aftercare program for substance abuse: decomposing measured and unmeasured gender differences.
    Yeom HS; Shepard DS
    J Ment Health Policy Econ; 2007 Dec; 10(4):207-19. PubMed ID: 18166831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Women and addiction: the importance of gender issues in substance abuse research.
    Tuchman E
    J Addict Dis; 2010 Apr; 29(2):127-38. PubMed ID: 20407972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender differences in drug toxicity.
    Nicolson TJ; Mellor HR; Roberts RR
    Trends Pharmacol Sci; 2010 Mar; 31(3):108-14. PubMed ID: 20117848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex and gender influences on pharmacological response: an overview.
    Franconi F; Campesi I
    Expert Rev Clin Pharmacol; 2014 Jul; 7(4):469-85. PubMed ID: 24857340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in pharmacokinetics and pharmacodynamics.
    Beierle I; Meibohm B; Derendorf H
    Int J Clin Pharmacol Ther; 1999 Nov; 37(11):529-47. PubMed ID: 10584975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex differences in drug effects: interaction with sex hormones in adult life.
    Spoletini I; Vitale C; Malorni W; Rosano GM
    Handb Exp Pharmacol; 2012; (214):91-105. PubMed ID: 23027447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological basis of sex differences in drug abuse: preclinical and clinical studies.
    Lynch WJ; Roth ME; Carroll ME
    Psychopharmacology (Berl); 2002 Nov; 164(2):121-37. PubMed ID: 12404074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sex differences in pharmacology].
    Brøsen K
    Ugeskr Laeger; 2007 Jun; 169(25):2408-11. PubMed ID: 17594829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender issues and the pharmacotherapy of substance abuse.
    Heading CE
    IDrugs; 2008 Jun; 11(6):428-32. PubMed ID: 18509784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender differences in drug addiction and treatment: implications for social work intervention with substance-abusing women.
    Nelson-Zlupko L; Kauffman E; Dore MM
    Soc Work; 1995 Jan; 40(1):45-54. PubMed ID: 7863372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Training the next generation of providers in addiction medicine.
    Rasyidi E; Wilkins JN; Danovitch I
    Psychiatr Clin North Am; 2012 Jun; 35(2):461-80. PubMed ID: 22640766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex and gender differences in clinical medicine.
    Regitz-Zagrosek V; Seeland U
    Handb Exp Pharmacol; 2012; (214):3-22. PubMed ID: 23027443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender and polypharmacotherapy in the elderly: a clinical challenge.
    Hofer-Dückelmann C
    Handb Exp Pharmacol; 2012; (214):169-82. PubMed ID: 23027451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Placebo effects and adverse effects in clinical trials].
    Weihrauch TR
    Med Klin (Munich); 2000 May; 95(1 Spec No):23-30. PubMed ID: 10851845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Children of substance abusers: overview of research findings.
    Johnson JL; Leff M
    Pediatrics; 1999 May; 103(5 Pt 2):1085-99. PubMed ID: 10224196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DHEA, important source of sex steroids in men and even more in women.
    Labrie F
    Prog Brain Res; 2010; 182():97-148. PubMed ID: 20541662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Women's programs versus mixed-gender day treatment: results from a randomized study.
    Kaskutas LA; Zhang L; French MT; Witbrodt J
    Addiction; 2005 Jan; 100(1):60-9. PubMed ID: 15598193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.